Legal Representation
Attorney
Andrea M. Porterfield
USPTO Deadlines
Next Deadline
20 days remaining
Non-Final Action Mailed
Due Date
August 14, 2025
Extension Available
Until November 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 14, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 14, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 14, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 11, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 11, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 19, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicinal preparations used as a narcotic antagonist; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations.
Class 010
Medical kits.
Class 020
Medicine cabinets.
Class 035
Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online pharmacy services.
Class 044
Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists.
Additional Information
Design Mark
The mark consists of the words "Padagis" above "Naloxone +".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
010
020
035
044